461 related articles for article (PubMed ID: 7130336)
1. Hypocitraturia in calcium nephrolithiasis.
Rudman D; Kutner MH; Redd SC; Waters WC; Gerron GG; Bleier J
J Clin Endocrinol Metab; 1982 Dec; 55(6):1052-7. PubMed ID: 7130336
[TBL] [Abstract][Full Text] [Related]
2. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
3. Causes of hypocitraturia in recurrent calcium stone formers: focusing on urinary potassium excretion.
Domrongkitchaiporn S; Stitchantrakul W; Kochakarn W
Am J Kidney Dis; 2006 Oct; 48(4):546-54. PubMed ID: 16997050
[TBL] [Abstract][Full Text] [Related]
4. Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis.
Mossetti G; Vuotto P; Rendina D; Numis FG; Viceconti R; Giordano F; Cioffi M; Scopacasa F; Nunziata V
J Intern Med; 2003 Feb; 253(2):194-200. PubMed ID: 12542560
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic hypocitraturic calcium-oxalate nephrolithiasis successfully treated with potassium citrate.
Pak CY; Fuller C
Ann Intern Med; 1986 Jan; 104(1):33-7. PubMed ID: 3940503
[TBL] [Abstract][Full Text] [Related]
6. [Citrate and kidney stones].
Osther PJ
Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
[TBL] [Abstract][Full Text] [Related]
7. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
[TBL] [Abstract][Full Text] [Related]
8. Renal excretion of citrate in patients with chronic renal failure or nephrolithiasis.
Chen SM; Chung LC; Lee YH; Young TK
J Formos Med Assoc; 1991 Jan; 90(1):41-7. PubMed ID: 1679108
[TBL] [Abstract][Full Text] [Related]
9. [The significance of hypocitruria in calcium oxalate induced nephrolithiasis].
Horváth C; Németh J; Büki B; Vargha P
Orv Hetil; 1990 Nov; 131(45):2475-8. PubMed ID: 2234941
[TBL] [Abstract][Full Text] [Related]
10. Hypocitraturia in patients with gastrointestinal malabsorption.
Rudman D; Dedonis JL; Fountain MT; Chandler JB; Gerron GG; Fleming GA; Kutner MH
N Engl J Med; 1980 Sep; 303(12):657-61. PubMed ID: 7402252
[TBL] [Abstract][Full Text] [Related]
11. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment.
Caudarella R; Vescini F
Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682
[TBL] [Abstract][Full Text] [Related]
12. The effect of sodium bicarbonate upon urinary citrate excretion in calcium stone formers.
Pinheiro VB; Baxmann AC; Tiselius HG; Heilberg IP
Urology; 2013 Jul; 82(1):33-7. PubMed ID: 23602798
[TBL] [Abstract][Full Text] [Related]
13. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
Pak CY; Sakhaee K; Fuller CJ
Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cocoa on excretion of oxalate, citrate, magnesium and calcium in the urine of children].
Lagemann M; Anders D; Graef V; Bödeker RH
Monatsschr Kinderheilkd; 1985 Oct; 133(10):754-9. PubMed ID: 4069117
[TBL] [Abstract][Full Text] [Related]
15. Body size and 24-hour urine composition.
Taylor EN; Curhan GC
Am J Kidney Dis; 2006 Dec; 48(6):905-15. PubMed ID: 17162145
[TBL] [Abstract][Full Text] [Related]
16. Urinary stone formers with hypocitraturia and 'normal' urinary pH are at high risk for recurrence.
Strohmaier WL; Seilnacht J; Schubert G
Urol Int; 2012; 88(3):294-7. PubMed ID: 22398801
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic calcium nephrolithiasis. 2. Differences between hypercalciuric and normocalciuric persons with recurrent kidney stone formation and persons without such a history.
Wilson DR; Pylypchuk G; Ehrig U
Can Med Assoc J; 1979 Mar; 120(6):666-9. PubMed ID: 436048
[TBL] [Abstract][Full Text] [Related]
18. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
[TBL] [Abstract][Full Text] [Related]
19. Urinary citrate in kidney stone disease.
Usui Y; Matsuzaki S; Matsushita K; Shima M
Tokai J Exp Clin Med; 2003 Jul; 28(2):65-70. PubMed ID: 14714831
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and low urinary citrate excretion in calcium stone formers.
Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
